| Mar 1, 2026 |
Mar 3, 2026 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-3,321
|
-0.26%
|
✗
|
$707.4 |
| Mar 1, 2026 |
Mar 3, 2026 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
50.0
|
-2,283
|
-0.61%
|
✗
|
$486.3 |
| Mar 1, 2026 |
Mar 3, 2026 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Sell |
47.5
|
-5,867
|
-1.40%
|
✗
|
$1.2K |
| Feb 26, 2026 |
Feb 27, 2026 |
Forterre Gael
|
Chief Commercial Officer |
Neutral |
90.0
|
+149,000
|
65.53%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Rubin Ethel
|
Director |
Neutral |
90.0
|
+178,000
|
237.50%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Reynolds Cameron John
|
CEO |
Neutral |
90.0
|
+486,000
|
13.24%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Neutral |
90.0
|
+142,000
|
67.15%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Hughes Terig
|
CFO |
Neutral |
90.0
|
+202,000
|
41.82%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Rootsaert Rodney Gerard
|
Secretary |
Neutral |
90.0
|
+119,000
|
10.17%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Neutral |
90.0
|
+187,000
|
80.21%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Nguyen Kim
|
Director |
Neutral |
90.0
|
+178,000
|
112.39%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Kway Jasmine
|
CEO |
Neutral |
90.0
|
+173,000
|
67.57%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Micallef Jacob Vincent
|
Chief Scientific Officer |
Neutral |
90.0
|
+149,000
|
28.57%
|
✗
|
- |
| Feb 26, 2026 |
Feb 27, 2026 |
Innes Guy Archibald
|
Director |
Neutral |
85.0
|
+178,000
|
5.16%
|
✗
|
- |
| Feb 1, 2026 |
Feb 3, 2026 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
50.0
|
-2,010
|
-0.88%
|
✗
|
$572.9 |
| Feb 1, 2026 |
Feb 3, 2026 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-3,196
|
-0.27%
|
✗
|
$910.9 |
| Feb 1, 2026 |
Feb 3, 2026 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Sell |
47.5
|
-5,647
|
-2.36%
|
✗
|
$1.6K |
| Jan 22, 2026 |
Jan 23, 2026 |
Rubin Ethel
|
Director |
Neutral |
90.0
|
+12,000
|
19.06%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Innes Guy Archibald
|
Director |
Neutral |
60.0
|
+12,000
|
0.35%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Forterre Gael
|
Chief Commercial Officer |
Neutral |
90.0
|
+38,100
|
19.92%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Reynolds Cameron John
|
CEO |
Neutral |
77.5
|
+74,700
|
2.08%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Colman Alan
|
Director |
Neutral |
82.5
|
+12,000
|
4.89%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
STILL TIMOTHY I
|
Director |
Neutral |
85.0
|
+90,000
|
5.86%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Neutral |
90.0
|
+33,900
|
19.09%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Hughes Terig
|
CFO |
Neutral |
90.0
|
+49,200
|
11.34%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Barnes Phillip
|
Director |
Neutral |
90.0
|
+12,000
|
21.67%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Butera Salvatore Thomas
|
CEO |
Neutral |
90.0
|
+53,400
|
16.59%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Rootsaert Rodney Gerard
|
Secretary |
Neutral |
77.5
|
+28,200
|
2.46%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Micallef Jacob Vincent
|
Chief Scientific Officer |
Neutral |
85.0
|
+35,400
|
7.28%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Neutral |
90.0
|
+44,700
|
23.03%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Henshall Mickie
|
Director |
Neutral |
90.0
|
+12,000
|
37.26%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Nguyen Kim
|
Director |
Neutral |
85.0
|
+12,000
|
8.20%
|
✗
|
- |
| Jan 22, 2026 |
Jan 23, 2026 |
Kway Jasmine
|
CEO |
Neutral |
90.0
|
+42,000
|
19.62%
|
✗
|
- |
| Nov 17, 2025 |
Nov 17, 2025 |
Reynolds Cameron John
|
CEO |
Buy |
67.5
|
+20,000
|
0.56%
|
✗
|
$7K |
| Nov 1, 2025 |
Nov 4, 2025 |
Retter Andrew
|
Chief Medical Officer |
Sell |
47.5
|
-4,588
|
-3.04%
|
✗
|
$2K |
| Nov 1, 2025 |
Nov 4, 2025 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Sell |
47.5
|
-5,647
|
-2.83%
|
✗
|
$2.5K |
| Nov 1, 2025 |
Nov 4, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-3,197
|
-0.28%
|
✗
|
$1.4K |
| Nov 1, 2025 |
Nov 4, 2025 |
Butera Salvatore Thomas
|
CEO |
Sell |
47.5
|
-4,648
|
-1.42%
|
✗
|
$2K |
| Nov 1, 2025 |
Nov 4, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
50.0
|
-1,753
|
-0.91%
|
✗
|
$760.8 |
| Oct 14, 2025 |
Oct 15, 2025 |
Reynolds Cameron John
|
CEO |
Buy |
87.5
|
+110,000
|
3.17%
|
✗
|
$56.1K |
| Oct 14, 2025 |
Oct 15, 2025 |
Innes Guy Archibald
|
Director |
Buy |
83.8
|
+96,153
|
2.88%
|
✗
|
$49K |
| Oct 14, 2025 |
Oct 15, 2025 |
STILL TIMOTHY I
|
Director |
Buy |
83.8
|
+48,076
|
3.23%
|
✗
|
$24.5K |
| Oct 4, 2025 |
Oct 7, 2025 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Sell |
47.5
|
-6,110
|
-3.33%
|
✗
|
$4K |
| Oct 4, 2025 |
Oct 7, 2025 |
Butera Salvatore Thomas
|
CEO |
Sell |
47.5
|
-5,834
|
-1.76%
|
✗
|
$3.8K |
| Oct 4, 2025 |
Oct 7, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-4,620
|
-0.40%
|
✗
|
$3K |
| Oct 4, 2025 |
Oct 7, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
47.5
|
-5,389
|
-2.72%
|
✗
|
$3.5K |
| Oct 4, 2025 |
Oct 7, 2025 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Sell |
47.5
|
-8,146
|
-3.92%
|
✗
|
$5.3K |
| Oct 4, 2025 |
Oct 7, 2025 |
Michel Gaetan
|
COO |
Sell |
47.5
|
-12,333
|
-4.58%
|
✗
|
$8K |
| Oct 4, 2025 |
Oct 7, 2025 |
Micallef Jacob Vincent
|
Chief Scientific Officer |
Sell |
47.5
|
-5,850
|
-1.19%
|
✗
|
$3.8K |
| Sep 28, 2025 |
Sep 30, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-4,158
|
-0.36%
|
✗
|
$2.5K |
| Sep 28, 2025 |
Sep 30, 2025 |
Butera Salvatore Thomas
|
CEO |
Sell |
47.5
|
-5,230
|
-1.55%
|
✗
|
$3.2K |
| Sep 28, 2025 |
Sep 30, 2025 |
Micallef Jacob Vincent
|
Chief Scientific Officer |
Sell |
47.5
|
-5,568
|
-1.12%
|
✗
|
$3.4K |
| Sep 28, 2025 |
Sep 30, 2025 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Sell |
47.5
|
-5,604
|
-2.96%
|
✗
|
$3.4K |
| Sep 28, 2025 |
Sep 30, 2025 |
Michel Gaetan
|
COO |
Sell |
47.5
|
-11,362
|
-2.99%
|
✗
|
$6.9K |
| Sep 28, 2025 |
Sep 30, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
47.5
|
-5,503
|
-2.70%
|
✗
|
$3.3K |
| Sep 12, 2025 |
Sep 15, 2025 |
Reynolds Cameron John
|
CEO |
Buy |
60.0
|
+15,000
|
0.41%
|
✗
|
$9.9K |
| Aug 15, 2025 |
Aug 19, 2025 |
Hughes Terig
|
CFO |
Neutral |
85.0
|
+26,143
|
5.15%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Neutral |
90.0
|
+27,400
|
16.92%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Neutral |
77.5
|
+15,223
|
1.33%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Butera Salvatore Thomas
|
CEO |
Neutral |
90.0
|
+33,991
|
11.20%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Retter Andrew
|
Chief Medical Officer |
Neutral |
90.0
|
+19,524
|
14.83%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Neutral |
90.0
|
+24,031
|
13.07%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Rubin Ethel
|
Director |
Neutral |
90.0
|
+17,424
|
38.27%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Nguyen Kim
|
Director |
Neutral |
90.0
|
+17,424
|
13.51%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Kway Jasmine
|
CEO |
Neutral |
85.0
|
+12,507
|
6.21%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Neutral |
85.0
|
+9,727
|
5.01%
|
✗
|
- |
| Aug 5, 2025 |
Aug 6, 2025 |
Innes Guy Archibald
|
Director |
Buy |
82.5
|
+78,125
|
2.39%
|
✗
|
$50K |
| Aug 5, 2025 |
Aug 6, 2025 |
Reynolds Cameron John
|
CEO |
Buy |
82.5
|
+78,125
|
2.19%
|
✗
|
$50K |
| Aug 1, 2025 |
Aug 5, 2025 |
Butera Salvatore Thomas
|
CEO |
Sell |
47.5
|
-6,393
|
-2.06%
|
✗
|
$4.1K |
| Aug 1, 2025 |
Aug 5, 2025 |
Retter Andrew
|
Chief Medical Officer |
Sell |
47.5
|
-6,142
|
-4.46%
|
✗
|
$3.9K |
| Aug 1, 2025 |
Aug 5, 2025 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Sell |
47.5
|
-8,620
|
-5.06%
|
✗
|
$5.5K |
| Aug 1, 2025 |
Aug 5, 2025 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Sell |
47.5
|
-4,451
|
-2.36%
|
✗
|
$2.8K |
| Aug 1, 2025 |
Aug 5, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
47.5
|
-2,766
|
-1.40%
|
✗
|
$1.8K |
| Aug 1, 2025 |
Aug 5, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-4,279
|
-0.37%
|
✗
|
$2.7K |
| Jul 24, 2025 |
Jul 25, 2025 |
Hughes Terig
|
CFO |
Neutral |
90.0
|
+100,000
|
24.53%
|
✗
|
- |
| Jul 24, 2025 |
Jul 25, 2025 |
Reynolds Cameron John
|
CEO |
Neutral |
85.0
|
+200,000
|
5.93%
|
✗
|
- |
| Jul 1, 2025 |
Jul 3, 2025 |
Plummer Nicholas
|
GC - Volition Diagnostics |
Sell |
47.5
|
-5,417
|
-2.80%
|
✗
|
$4.2K |
| Jul 1, 2025 |
Jul 3, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
52.5
|
-3,066
|
-0.27%
|
✗
|
$2.4K |
| Jun 1, 2025 |
Jul 3, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
47.5
|
-1,996
|
-1.00%
|
✗
|
$1.5K |
| Jul 1, 2025 |
Jul 3, 2025 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Sell |
47.5
|
-6,177
|
-3.50%
|
✗
|
$4.7K |
| Jul 1, 2025 |
Jul 3, 2025 |
Butera Salvatore Thomas
|
CEO |
Sell |
47.5
|
-4,462
|
-1.42%
|
✗
|
$3.4K |
| Jul 1, 2025 |
Jul 3, 2025 |
Retter Andrew
|
Chief Medical Officer |
Sell |
47.5
|
-4,401
|
-3.10%
|
✗
|
$3.4K |
| Jun 12, 2025 |
Jun 16, 2025 |
Reynolds Cameron John
|
CEO |
Buy |
60.0
|
+12,500
|
0.37%
|
✗
|
$7.4K |
| Jun 3, 2025 |
Jun 4, 2025 |
Innes Guy Archibald
|
Director |
Buy |
68.8
|
+20,000
|
0.62%
|
✗
|
$10.8K |
| Jun 1, 2025 |
Jun 3, 2025 |
Kway Jasmine
|
CEO |
Neutral |
82.5
|
+8,327
|
4.31%
|
✗
|
- |
| Jun 1, 2025 |
Jun 3, 2025 |
Nguyen Kim
|
Director |
Neutral |
90.0
|
+11,983
|
10.24%
|
✗
|
- |
| Jun 1, 2025 |
Jun 3, 2025 |
Plummer Nicholas
|
GC, Volition Diagnostics |
Neutral |
85.0
|
+16,086
|
9.06%
|
✗
|
- |
| Jun 1, 2025 |
Jun 3, 2025 |
Michel Gaetan
|
COO |
Sell |
47.5
|
-7,835
|
-2.02%
|
✗
|
$3.9K |
| Jun 1, 2025 |
Jun 3, 2025 |
Rootsaert Rodney Gerard
|
Secretary |
Sell |
60.0
|
+3,782
|
0.33%
|
✗
|
$3.2K |
| Jun 1, 2025 |
Jun 3, 2025 |
Butera Salvatore Thomas
|
CEO |
Sell |
82.5
|
+11,694
|
3.86%
|
✗
|
$5.9K |
| Jun 1, 2025 |
Jun 3, 2025 |
Forterre Gael
|
Chief Commercial Officer |
Sell |
77.5
|
+2,456
|
1.25%
|
✗
|
$2.1K |
| Jun 1, 2025 |
Jun 3, 2025 |
Hughes Terig
|
CFO |
Neutral |
82.5
|
+17,406
|
4.46%
|
✗
|
- |
| Jun 1, 2025 |
Jun 3, 2025 |
Batchelor Ann-Louise
|
Group Chief Marketing Officer |
Neutral |
90.0
|
+18,341
|
11.58%
|
✗
|
- |
| Jun 1, 2025 |
Jun 3, 2025 |
Retter Andrew
|
Chief Medical Officer |
Sell |
85.0
|
+8,471
|
6.34%
|
✗
|
$2.3K |
| Jun 1, 2025 |
Jun 3, 2025 |
Micallef Jacob Vincent
|
Chief Scientific Officer |
Sell |
46.3
|
-21,526
|
-4.15%
|
✗
|
$10.8K |
| Jun 1, 2025 |
Jun 3, 2025 |
Rubin Ethel
|
Director |
Neutral |
90.0
|
+11,983
|
35.73%
|
✗
|
- |
| May 19, 2025 |
May 19, 2025 |
Micallef Jacob Vincent
|
Chief Scientific Officer |
Buy |
91.3
|
+50,000
|
10.66%
|
✗
|
$21.5K |
| May 19, 2025 |
May 19, 2025 |
Reynolds Cameron John
|
CEO |
Buy |
67.5
|
+20,000
|
0.60%
|
✗
|
$8.7K |
| May 1, 2025 |
May 5, 2025 |
Michel Gaetan
|
COO |
Sell |
47.5
|
-6,844
|
-1.73%
|
✗
|
$3.3K |
| May 1, 2025 |
May 5, 2025 |
Retter Andrew
|
Chief Medical Officer |
Sell |
47.5
|
-3,913
|
-2.84%
|
✗
|
$1.9K |